Physician profile
Irwin Lee
NPI 1649337486
$426.10
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $213 · 2020: $18.44 · 2021: $102 · 2022: $92.15.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gen-Probe Sales & Service, INC. | $102.13 | 2021 | |
| Roche Diagnostics Corporation | $56.01 | 2019-2020 | |
| Coopersurgical, INC. | $49.57 | 2019-2022 | |
| Abbvie INC. | $48.06 | 2019 | |
| Hologic Sales and Service, LLC | $43.21 | 2022 | |
| Covidien LP | $38.86 | 2019 | |
| Amgen INC. | $34.09 | 2019 | |
| Myovant Sciences INC. | $27.32 | 2022 | |
| Radius Health, INC. | $26.85 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irwin Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.